You will be the 2nd employee of the Company, reporting directly to the CEO, and in close connection with the medical Director.
You will be the 2nd employee of the Company, reporting directly to the CEO, and in close connection with the medical Director.
Study will evaluate INTERCIL in patients with primary open-angle glaucoma as Ciliatech advances US clinical development program Epagny Metz-Tessy, France, September 8, 2026 – Ciliatech, ....
Ciliatech is pleased to announce the publication of 24-month clinical data for INTERCIL® in Ophthalmology and Therapy. The publication, titled “A Prospective Evaluation of the ....
Ciliatech are delighted to announce the appointment of Saima Khokhar as International Scientific & Medical Affairs Manager, joining the company on a full-time basis to ....
This site is only for the use of professionals associated with the field of Ophthalmology and is not intended for patients.